Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Menopause. 2015 Jun;22(6):627–632. doi: 10.1097/GME.0000000000000374

Table 2.

Hot Flash Scores (A) and Frequencies (B) During Treatment

A. Mean Hot Flash Scores
Placebo (N=91) 1200 mg (N=88) 800 mg (N=88)
Mean (SD) N Mean (SD) N Mean (SD) N
Baseline 17.28 (10.84) 83 15.35 (10.53) 81 16.02 (9.62) 81
Week 1 15.52 (10.51) 86 14.47 (11.10) 78 14.28 (9.26) 81
Week 2 13.29 (9.46) 85 12.59 (10.01) 78 12.68 (8.87) 79
Week 3 12.34 (9.98) 83 11.32 (10.72) 76 12.29 (9.79) 78
Week 4 12.02 (9.57) 82 10.14 (8.61) 73 11.73 (10.35) 78
Week 5 11.63 (9.61) 79 9.73 (9.19) 67 11.77 (10.86) 75
Week 6 11.17 (8.78) 79 9.44 (8.99) 67 11.61 (10.46) 71
Week 7 10.71 (8.68) 78 9.37 (9.24) 67 11.92 (11.26) 71
Week 8 11.42 (10.32) 79 9.06 (8.87) 66 12.17 (10.88) 69
Repeated Measure (P-value) Growth Curve Model (P-value)
Mg 1200 Vs. Placebo 0.67 0.90
Mg 800 Vs. Placebo 0.13 0.26
B. Mean Hot Flash Frequencies
Placebo (N=91) 1200 mg (N=88) 800 mg (N=88)
Mean (SD) N Mean (SD) N Mean (SD) N
Baseline 8.89 (4.52) 83 7.55 (3.89) 81   8.48 (4.34) 81
Week 1 8.04 (4.59) 86 7.15 (4.13) 78 7.83 (4.34) 81
Week 2 7.26 (4.65) 85 6.51 (4.19) 78 7.12 (4.18) 79
Week 3 6.97 (4.82) 83 5.87 (4.21) 76 6.73 (4.41) 78
Week 4 6.73 (4.44) 82   5.34 (3.76) 73 6.39 (4.51) 78
Week 5 6.45 (4.33) 79 5.15 (4.00) 67 6.31 (4.70) 75
Week 6 6.37 (4.30) 79 4.95 (4.04) 67 6.34 (4.56) 71
Week 7 6.18 (4.23) 78 4.92 (4.13) 67 6.43 (4.68) 71
Week 8   6.38 (4.67) 79 4.88 (4.02) 66 6.61 (4.58) 69
Repeated Measure (P-value) Growth Curve Model (P-value)
Mg 1200 Vs. Placebo 0.55 0.80
Mg 800 Vs. Placebo 0.25 0.39